John L. Lundblad

Person

El Cerrito, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Viral inactivation process
- Patent number 4,939,176
- Issue date Jul 3, 1990
- Miles Inc.
- Richard L. Seng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pasteurized therapeutically active protein compositions
- Patent number 4,623,717
- Issue date Nov 18, 1986
- Miles Laboratories, Inc.
- Peter M. Fernandes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin compositions
- Patent number 4,455,300
- Issue date Jun 19, 1984
- Cutter Laboratories, Inc.
- Donald G. Wallace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antihemophilic factor concentrate
- Patent number 4,455,301
- Issue date Jun 19, 1984
- Cutter Laboratories, Inc.
- Gautam Mitra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pasteurized therapeutically active protein compositions
- Patent number 4,440,679
- Issue date Apr 3, 1984
- Cutter Laboratories, Inc.
- Peter M. Fernandes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition having enhanced opsonic activity
- Patent number 4,412,990
- Issue date Nov 1, 1983
- Cutter Laboratories, Inc.
- John L. Lundblad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antihemophilic factor concentrate and method for preparation
- Patent number 4,386,068
- Issue date May 31, 1983
- Cutter Laboratories, Inc.
- Gautam Mitra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of preparing fibronectin and antihemophilic factor
- Patent number 4,341,764
- Issue date Jul 27, 1982
- Cutter Laboratories, Inc.
- Donald G. Wallace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized immune serum globulin
- Patent number 4,186,192
- Issue date Jan 29, 1980
- Cutter Laboratories, Inc.
- John L. Lundblad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

John L. Lundblad

Person

Patents Grantslast 30 patents

Viral inactivation process

Pasteurized therapeutically active protein compositions

Fibronectin compositions

Antihemophilic factor concentrate

Pasteurized therapeutically active protein compositions

Composition having enhanced opsonic activity

Antihemophilic factor concentrate and method for preparation

Method of preparing fibronectin and antihemophilic factor

Stabilized immune serum globulin